January 2022

Brought to you by the Sassy Pharmacist

The FDA has approved atogepant oral tablets (Qulipta; AbbVie) for the preventive treatment of episodic migraines in adults.

Mental Health Parity and Addiction Equity Act disallows insurers offering lower-quality benefits for behavioral health treatments.

Pharmacists can offer guidance on proper use of therapies and encourage adherence to regimens.

This month features asciminib (Scemblix), pilocarpine HCI ophthalmic solution (Vuity), and amphetamine (Dyanavel XR).

They are in a unique position to evaluate patients in their practice settings to improve health outcomes.

This month's generic product news features generics for Robinul, Decadron, and Samsca.

2021 was almost as difficult as 2020; learn ways to start the new year with these recommendations.

This month's products features jelly bean vitamins, nail repair, and Mucinex InstaSoothe.

Agency aims to allow electronic prescriptions for schedule II to V drugs between registered retail pharmacies on 1-time basis for initial fill.

Did trial court judge err when dismissing the lawsuit without direct evidence of plaintiff’s claim?

Agency green light could help get medication off ASHP drug shortage list by reducing supply issues.

Pharmacies should address situations in which multiple bottles of tablets are used to refill a cassette.

How would you respond to these patients' questions?

Educate and remind patients to use appropriate OTC products to help protect, restore, and maintain the natural skin barrier.

Pharmacists can field dermatological questions and help provide relief for this uncomfortable ailment,

Compensation was a positive, while workload, management, and lack of work/life balance are the top reasons for dissatisfaction.

Pay for outcomes is here to stay, but are pharmacy claims an outdated source of quality measurement?

1960-2021